Final Analysis of a Trial of M72/AS01

Simple item page
dc.contributor.authorTait DR
dc.contributor.authorHatherill M
dc.contributor.authorVan Der Meeren O
dc.contributor.authorGinsberg AM
dc.contributor.authorVan Brakel E
dc.contributor.authorSalaun B
dc.contributor.authorScriba TJ
dc.contributor.authorAkite EJ
dc.contributor.authorAyles HM
dc.contributor.authorBollaerts A
dc.contributor.authorDemoitié MA
dc.contributor.authorDiacon A
dc.contributor.authorEvans TG
dc.contributor.authorGillard P
dc.contributor.authorHellström E
dc.contributor.authorInnes JC
dc.contributor.authorLempicki M
dc.contributor.authorMalahleha M
dc.contributor.authorMartinson N
dc.contributor.authorMesia Vela D
dc.contributor.authorMuyoyeta M
dc.contributor.authorNduba V
dc.contributor.authorPascal TG
dc.contributor.authorTameris M
dc.contributor.authorThienemann F
dc.contributor.authorWilkinson RJ
dc.contributor.authorRoman F
dc.date.accessioned2025-09-17T10:26:24Z
dc.date.issued2019-Dec-19
dc.description.abstractBACKGROUND: Results of an earlier analysis of a trial of the M72/AS01 METHODS: From August 2014 through November 2015, we enrolled adults 18 to 50 years of age with RESULTS: A total of 3575 participants underwent randomization, of whom 3573 received at least one dose of M72/AS01 CONCLUSIONS: Among adults infected with
dc.identifier.doi10.1056/NEJMoa1909953
dc.identifier.urihttps://pubs.cidrz.org/handle/123456789/12066
dc.identifier.uri.pubmedhttps://pubmed.ncbi.nlm.nih.gov/31661198/
dc.relation.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ)
dc.relation.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ)
dc.relation.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ)
dc.relation.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ)
dc.relation.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ)
dc.relation.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ)
dc.relation.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ)
dc.relation.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ)
dc.relation.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ)
dc.relation.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ)
dc.relation.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ)
dc.relation.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ)
dc.relation.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ)
dc.relation.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ)
dc.relation.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ)
dc.relation.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ)
dc.relation.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ)
dc.relation.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ)
dc.relation.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ)
dc.relation.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ)
dc.relation.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ)
dc.relation.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ)
dc.relation.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ)
dc.relation.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ)
dc.relation.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ)
dc.relation.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ)
dc.relation.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ)
dc.sourceThe New England journal of medicine
dc.titleFinal Analysis of a Trial of M72/AS01

Files

Collections

Published